Study: Delayed Second or Third AstraZeneca Doses Provides Better Immunity
According to a study by Oxford University delayed second or third AstraZeneca vaccine of results in a better immune response against the COVID-19 virus.
Gathogo Wanjiru 
According to the research, a long interval between the first and second doses does not impair the immune response after a late second dose, and a third dose of the vaccine continues to boost antibodies against COVID-19.
Researchers investigating the effects of a 45-week delay between the first and second doses in study participants discovered that antibody levels increased after the delayed second dose.
“Additionally, a longer delay between first and second doses may be beneficial, resulting in an increased antibody titer and enhanced immune response after the second dose,” the University of Oxford said on Monday.
According to Professor Sir Andrew Pollard of the Oxford University vaccine trial, there is an excellent response to a second dose, even after a 10-month delay from the first jab.
The study also indicated that the incidence of side effects was lower after the second and third doses than after the first.
